{
    "title": "Cancer risk of popular HRT drug",
    "url": "https://www.dailymail.co.uk/health/article-346653/Cancer-risk-popular-HRT-drug.html",
    "date": "2005-04-28",
    "keywords": [
        "hrt",
        "cancer",
        "womb",
        "risk",
        "breast",
        "health",
        "safety",
        "combination",
        "uk",
        "year",
        "treatment",
        "cent",
        "hormone",
        "dilemma",
        "treatmentthe",
        "use",
        "hrtthe",
        "advice",
        "study",
        "research",
        "director",
        "hysterectomy",
        "hand",
        "increase",
        "winterhalter",
        "concern",
        "need",
        "replacement",
        "pill",
        "hormonesbut",
        "discovery",
        "rethink",
        "company",
        "organon",
        "decision",
        "agreement",
        "healthcare",
        "agency",
        "mhra",
        "light",
        "evidenceorganon",
        "trial",
        "livial",
        "end",
        "brandlivial",
        "brand",
        "oxford",
        "university",
        "journal",
        "periodthis",
        "rate",
        "hrtan",
        "percentage",
        "link",
        "reason",
        "leader",
        "professor",
        "epidemiology",
        "unit",
        "tibolone",
        "oestrogen",
        "progesterone",
        "cancersince",
        "cancerat",
        "start",
        "figure",
        "department",
        "england",
        "executive",
        "charity",
        "message",
        "understand",
        "kind",
        "doctorno",
        "change",
        "policy",
        "dont",
        "think",
        "bleeding",
        "benefitprofessor",
        "gordon",
        "duff",
        "chairman",
        "committee",
        "government",
        "medicine",
        "data",
        "individual",
        "action",
        "prescriber",
        "helpline",
        "counsellingwomenshealthconcernorg"
    ],
    "category": [
        "health"
    ]
}